PDS Biotechnology Corporation
DE ˙ DB ˙ US70465T1079
€ 0,99 0.00 (0.00%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:EU6 / PDS Biotechnology Corporation
InstitutionXTX Topco Ltd
Latest Disclosed Ownership36,211 shares
Latest Disclosed Value $ 21,908
XTX Topco Ltd reports 5.82% increase in ownership of EU6 / PDS Biotechnology Corporation

On May 15, 2026 - XTX Topco Ltd filed a 13F-HR form disclosing ownership of 36,211 shares of PDS Biotechnology Corporation (DE:EU6) valued at $16,824 USD as of March 31, 2026. The current value of the position is $35,994 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 36,211 1,993 5.82 22 -19.23 0.0004
2026-02-17 2025-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 34,218 14,519 73.70 26 36.84 0.0007
2025-11-14 2025-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 19,699 19,699 20 0.0010
2025-05-08 2025-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 0 -24,535 -100.00 0 -100.00
2025-02-13 2024-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 24,535 -42,647 -63.48 40 -84.77 0.0033
2024-11-14 2024-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 67,182 47,528 241.82 257 349.12 0.0186
2024-08-12 2024-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 19,654 -40,600 -67.38 58 -76.05 0.0049
2024-05-13 2024-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 60,254 60,254 239 0.0322
2022-11-14 2022-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 0 -21,085 -100.00 0 -100.00
2022-08-15 2022-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 21,085 21,085 77 0.0315
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.